跳至主要内容
临床试验/EUCTR2012-000292-16-ES
EUCTR2012-000292-16-ES进行中(未招募)不适用

Phase IIa clinical trial to test the feasibility and safety of using autologous mesenchymal stem cells from fat in the local treatment of bronchopleural fistula - HULPTOR

Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP)0 个研究点开始时间: 2013年4月9日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Being over 18 years
  • 2 Having accessible bronchopleural fistula pathology endoscopic approach.
  • 3. Prior control of the fistula with the usual techniques ((pleural drainage, infection control, open thoracostomy and / or endotracheal prosthesis-bronchial)
  • 4. Fistula refracted to conventional medical or surgical treatment.
  • 5. Have signed the informed consent
  • 6. Negative pregnancy test and acceptance of the use of highly effective contraceptive methods if applicable.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Mental retardation incapacitating signing the informed consent.
  • 2. Urgency in treatment.
  • 3. Pleural cavity with uncontrolled infection.
  • 4. Extreme malnutrition (BMI <18.5 kg/m2) who advise against liposuction.
  • 5. Presence of uncontrolled malignancy or progression phase.
  • 6. Inability to tolerate the anesthetic and / or bronchoscopic implant required for ASC.
  • 7. Administration of any investigational drug at present to three months prior to enrollment for this trial.
  • 8. Infants and pregnant women.
  • 9. Adult women of childbearing age not using effective contraception as ICH guidance M3 EMA during the test.

研究者

发起方
Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP)

相似试验

进行中(未招募)
1 期
Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipose derived adult mesenchymal stem cells expanded and pulsed with H2O2, in patients with acute traumatic spinal cord injury.Patients with acute traumatic spinal cord injuryMedDRA version: 18.1Level: LLTClassification code 10043064Term: T7-T12 level spinal cord injury, unspecifiedSystem Organ Class: 100000004863MedDRA version: 18.1Level: LLTClassification code 10043046Term: T1-T6 level spinal cord injury, unspecifiedSystem Organ Class: 100000004863
EUCTR2015-005717-80-ESFerrer Internacional S.A
进行中(未招募)
1 期
The proposal is to join a clinical research study in Phase IIa to test the feasibility and safety of a new therapeutic application based on the use of stem cells derived from lipoaspirate (ASC).Keratopathy associated with bilateral limbic insufficiency.
EUCTR2010-024328-53-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz
进行中(未招募)
1 期
The proposal is to join a Phase II clinical trial to test the feasibility and safety of a new therapeutic application based on the use of mesenchymal stem cells derived from adipose tissue (ASC) that is being made in various international hospitals.
EUCTR2010-024331-16-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz
进行中(未招募)
不适用
Clinical trial to evaluate the feasibility and safety of the intracerebral infusion of stem cells in patients with cerebral stroke
EUCTR2011-001393-26-ESFundación para la Investigación Biomédica del Hospital Clínico San Carlos
进行中(未招募)
1 期
A phase IIa clinical trial to demonstrate the proof of concept of an experimental pediculicide lotion for the treatment of head lice
EUCTR2005-005512-24-GBEctoPharma Limited20
ocal treatment of bronchopleural fistula with adilts... | 临床试验